Documents

Discussions Technicals Forecast Seasonals Bonds

Pharming Group NV documents

Explore the latest documents from Pharming Group NV, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Data partner

Description

Reported date

Form

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 08, 2025

Transcript

Q2 2025

Jul 31, 2025

Transcript

Interim report

Slides

Study Update

Jun 30, 2025

Press release

Slides

AGM 2025

Jun 11, 2025

Slides

Jefferies Global Healthcare Conference 2025

Jun 05, 2025

Slides

Q1 2025

May 08, 2025

Transcript

Slides

Interim report

24th Annual Needham Virtual Healthcare Conference

Apr 08, 2025

Slides

Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 12, 2025

Transcript

Slides

2024

Q4 2024

Mar 13, 2025

Transcript

Annual report20-F

Slides

Interim report

M&A Announcement

Dec 16, 2024

Press release

Jefferies London Healthcare Conference 2024

Nov 20, 2024

Slides

Q3 2024

Oct 24, 2024

Slides

Interim report

H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 09, 2024

Slides

Wells Fargo 2024 Healthcare Conference

Sep 06, 2024

Slides

H1 2024

Aug 01, 2024

Interim report

Slides

Jefferies 2024 Global Healthcare Conference

Jun 05, 2024

Slides

AGM 2024

May 21, 2024

Slides

Q1 2024

May 08, 2024

Slides

Interim report

23rd Annual Needham Virtual Healthcare Conference

Apr 08, 2024

Slides

Oppenheimer 34th Annual Healthcare Life Sciences Conference (Virtual)

Feb 13, 2024

Slides

2023

H2 2023

Mar 14, 2024

Annual report20-F

Annual report

Slides

Q3 2023

Oct 26, 2023

Interim report

Slides

H1 2023

Aug 03, 2023

Interim report

Slides

Q1 2023

May 11, 2023

Slides

Interim report

2022

H2 2022

Mar 16, 2023

Annual report20-F

Annual report

Slides

Q3 2022

Oct 27, 2022

Slides

Interim report

H1 2022

Aug 04, 2022

Slides

Interim report